Brief: Cardiol Therapeutics Files For Mixed Shelf Of Up To $150 Million
05/11/2025 23:20
Nov 5 (Reuters) - Cardiol Therapeutics Inc CRDL.TO: CARDIOL THERAPEUTICS INC FILES FOR MIXED SHELF OF UP TO $150 MILLION - SEC FILING Source text: [ID:n0001104659-25-107089] Further company coverage: CRDL.TO ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cardiol Therapeutics
See all newsBrief: Cardiol Therapeutics Achieves Phase III Maveric Enrollment Target Ahead Of Schedule And Expands Pivotal Trial To Strengthen Assessment Of Cardiolrx's Efficacy
Brief: Cardiol Therapeutics Files US$150 Million Preliminary Base Shelf Prospectus
Brief: Cardiol Therapeutics Files For Mixed Shelf Offering Of Up To $150 Mln
Brief: Cardiol Therapeutics Initiated Pivotal Phase Iii Maveric Trial Of Cardiolrx In Recurrent Pericarditis
NASDAQ RESUMED AT 09:00 AM